GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK…
GlycoMantra will present at the Oncology Investor Conference.
GlycoMantra has been selected to pitch at the NYC Spring Oncology Investor Conference 2020.
GlycoMantra will present at the Oncology Investor Conference.
GlycoMantra has been selected to pitch at the NYC Spring Oncology Investor Conference 2020.